Nucleic Acid, Nucleoside, or Nucleotide – Page 9

Agilent Technologies Acquires Biovectra for $925 Million to Enhance Biologics and CRISPR Capabilities

9 months ago talkbio0Tagged Acquisition (action), Agilent Technologies, Biological Factors, Biovectra, CDMO, Clustered Regularly Interspaced Short Palindromic Repeats, Contract agreement, Manufacturing Organization

Agilent Technologies, Biovectra, Acquisition, Biologics, CRISPR, Contract Development and Manufacturing Organization (CDMO)

Ionis Advances to Phase 3 Trial for Angelman Syndrome Treatment ION582

9 months ago talkbio0Tagged Angelman Syndrome, Antisense, Biogen, Dosage Forms, ION582, Ionis Pharmaceuticals, neurological conditions, Oligonucleotides, Phase 3 trial, Ultragenyx

Ionis Pharmaceuticals, Angelman syndrome, ION582, Phase 3 trial, antisense oligonucleotides, neurological conditions, rare diseases, Biogen, Ultragenyx Pharmaceutical

FTC to Sue Major PBMs Over Insulin and Drug Prices Amid Anticompetitive Concerns

10 months ago talkbio0Tagged anticompetitive, Benefit, health companies, Insulin, legal action, manager, PBMs, Pharmaceutical Services, Practice Experience, Prices, United States Federal Trade Commission

FTC, PBMs, Insulin Prices, Drug Prices, Anticompetitive Practices, Pharmacy Benefit Managers, Health Companies, Legal Action

US Government Appeals Jury Decision in High-Stakes HIV PrEP Patent Battle Against Gilead

10 months ago talkbio0Tagged battle, Descovy, Government, HIV, Legal patent, Litigation, PREP gene, Truvada

HIV, PrEP, Patent Battle, Gilead, Truvada, Descovy, US Government, Patent Litigation

Moderna Secures $176 Million BARDA Award for Bird Flu Vaccine Development

10 months ago talkbio0Tagged BARDA, development aspects, Influenza in Birds, Moderna, pandemic preparedness, RNA, Messenger, Vaccines

Moderna, BARDA, Bird Flu, Vaccine Development, mRNA Technology, Pandemic Preparedness

Arc Institute Unveils Revolutionary Bridge Editing Technology for Programmable Genome Design

10 months ago talkbio0Tagged Arc Institute, Bridge editing, Clustered Regularly Interspaced Short Palindromic Repeats, gene editor, Genetic Engineering, Genome, RNA-guided systems

Bridge editing, genome design, programmable gene editor, DNA strands, Arc Institute, CRISPR, RNA-guided systems, genetic engineering

CRISPR Gene Editing Therapy Can Be Administered Twice, Intellia Study Suggests

10 months ago talkbio0Tagged Amyloidosis, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, gene therapy, Intellia, Prealbumin, re-dosing

CRISPR, gene editing, Intellia Therapeutics, transthyretin amyloidosis, gene therapy, re-dosing

Exsilio Therapeutics Launches with $82 Million to Develop mRNA-Based Genomic Medicines Under Tal Zaks’ Leadership

10 months ago talkbio0Tagged Approved, Exsilio, Gene Modification, gene therapy, genomic medicines, Lipids, nanoparticle delivery, RNA, Messenger, safety profile, Tal Zaks

Exsilio Therapeutics, mRNA, genomic medicines, Tal Zaks, gene therapy, gene editing, lipid nanoparticle delivery, redosing, safety profile, gene therapy approval